NCT05822791Active, not recruiting
Differences in ECG- vs. proLonged cardIac MonItor-DeTected Atrial Fibrillation in STROKE Patients (DELIMIT AF-STROKE)
Differences in ECG- vs. proLonged cardIac MonItor-DeTected Atrial Fibrillation in STROKE Patients
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
The present study is an investigator-initiated, single-center, retrospective study based on data from the London Ontario Stroke Registry (LOSR), aiming to compare the characteristics and outcomes of ECG-detected and Device-Detected atrial fibrillation in patients with ischemic stroke and transient ischemic attack.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 366 (estimated)
- First submitted
- 31 Mar 2023
- Start date
- 1 May 2023
- Primary completion date
- 20 Jul 2027
- Lead sponsor
- Luciano A. Sposato
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT05822791
What you commit to
- Study type: Observational
- Planned participants: 366
- From 1 May 2023 to the primary completion date, 20 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Individuals younger than18 years-old
- Patients without IS or TIA diagnosis
Who the study is looking for
- Age ≥18 years
- Patient with a diagnosis of ischemic stroke or TIA.
- ECG-diagnosed AF or PCM-detected AF post ischemic stroke or TIA
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Heart & Brain Lab, Western University Coordinator of this site? Confirm its status | London | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.